- Home
- TIGR vs BHVN Comparison
TIGR vs BHVN Comparison
Compare TIGR & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGR
- BHVN
- Stock Information
- Founded
- TIGR 2014
- BHVN 2013
- Country
- TIGR Singapore
- BHVN United States
- Employees
- TIGR N/A
- BHVN N/A
- Industry
- TIGR Investment Bankers/Brokers/Service
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- TIGR Finance
- BHVN Health Care
- Exchange
- TIGR Nasdaq
- BHVN Nasdaq
- Market Cap
- TIGR 1.7B
- BHVN 1.4B
- IPO Year
- TIGR 2019
- BHVN 2017
- Fundamental
- Price
- TIGR $11.31
- BHVN $13.74
- Analyst Decision
- TIGR Strong Buy
- BHVN Strong Buy
- Analyst Count
- TIGR 2
- BHVN 14
- Target Price
- TIGR $10.79
- BHVN $58.85
- AVG Volume (30 Days)
- TIGR 8.6M
- BHVN 1.6M
- Earning Date
- TIGR 08-29-2025
- BHVN 08-07-2025
- Dividend Yield
- TIGR N/A
- BHVN N/A
- EPS Growth
- TIGR 93.97
- BHVN N/A
- EPS
- TIGR 0.46
- BHVN N/A
- Revenue
- TIGR $374,147,409.00
- BHVN N/A
- Revenue This Year
- TIGR $53.82
- BHVN $3.00
- Revenue Next Year
- TIGR $13.18
- BHVN $59.97
- P/E Ratio
- TIGR $23.89
- BHVN N/A
- Revenue Growth
- TIGR 61.42
- BHVN N/A
- 52 Week Low
- TIGR $3.36
- BHVN $13.04
- 52 Week High
- TIGR $14.48
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- TIGR 69.00
- BHVN 44.29
- Support Level
- TIGR $9.62
- BHVN $13.30
- Resistance Level
- TIGR $11.52
- BHVN $15.37
- Average True Range (ATR)
- TIGR 0.67
- BHVN 0.84
- MACD
- TIGR 0.10
- BHVN 0.06
- Stochastic Oscillator
- TIGR 91.73
- BHVN 30.04
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.